Given the demonstrated efficient cytotoxicity against MM, and cytokine production profile of our CS1-dbBiTE armed T cells in vitro, we hypothesized that armed T cells would possess superior anti-tumor efficacy against wildtype MM.1S tumor bearing mice over CS1-knockout MM xenograft mice. Here, SLAMF7 is linked to Miyoshi myopathy.